Effect of Tannato Iron (II) and Ascorbato Tannato Iron (II) on Anemic Albino Male Rats

Main Article Content

Rahma Al-Hammali
Haneen Alkashkari
Mabrouka Abdullah
Sultanah Mohammed
Husniyah Abdioy
Aisha Al-abbasi

Abstract

The aim of this study was to determine effects of Tannato iron (II) and Ascorbato tannato iron (II) on Anemic albino male rats. Anemia was induced by repeated extraction of about 0.6 mL blood daily from caudal vein within 6 consecutive days. Rats with Hemoglobin levels lower than 12g/dL  were considered anemic.  Twenty of albino male rats that were divided into four groups of 5 rats, including the normal control group, the anemic control group, the anemic group received Tannato iron (II), and the anemic group received Ascorbato tannato iron (II) at dosage 10mg/Kg body weight daily for 30 days. At the end of the study rats were anesthetized and blood was collected to determine complete blood count test, iron metabolism parameters, liver and kidney functions tests, and determine liver, kidney and spleen weight ratio to body weight. The results were shown that the treatment with tested compounds caused improve in anemia state by increase in RBCs, HGB HCT and iron levels. While there were a decrease in TIBC levels although decrease in ferritin levels. And results of liver and kidney function were within normal levels except slight increase in urea and decrease in direct bilirubin. And shown a decrease in liver weight, an increase in kidney weight, and no effects on spleen weight ratio to body weight. And these results indicate that there were no toxic effects  of tested iron compounds. And Tannato iron (II) compound had better effects of Ascorbato tannato iron (II) compound. 

Article Details

How to Cite
Al-Hammali ر. م., Alkashkari ح. ع., Abdullah م. م., Mohammed س. ع., Abdioy ح. م., & Al-abbasi ع. أ. (2024). Effect of Tannato Iron (II) and Ascorbato Tannato Iron (II) on Anemic Albino Male Rats. Sebha University Conference Proceedings, 3(2), 442–448. https://doi.org/10.51984/sucp.v3i2.3417
Section
Confrence Proceeding

References

Akbarpour, E., Paridar, Y., Mohammadi, Z., Mard, A., Danehchin, L., Abonezhadiar, F., Azadpour, S., Rahimi, Z., Zamani, M., Cheraghian, B., Poustchi, H. and Shayesteh, A-A. (2022). Anemia prevalence, severity, types, and correlates among adult women and men in a multiethnic Iranian population: the Khuzestan Comprehensive Health Study (KCHS). BMC Public Health. 22(168).

Balarajan, Y., Ramakrishnan, U., OIzaltin, U., Shankar, A, H. and Subramanian, S, V. (2011). Anaemia in low-income and middle-income countries. Lancet. 378: 2123-2135.

Thakur, M, K., Kulkarni, S, S., Mohanty, N., Kadam, N, N. and Swain, N, S. (2019). Standardization & Development of Rat Model with Iron Deficiency Anaemia Utilising Commercial Available Iron Deficient Food. Biosciences Biotechnology Research. 16(1): 71-77.

Piskin, E., Cianciosi, D., Gulec, S., Tomas, M. and Capanoglu, E. (2022). Iron Absorption: Factors, Limitations, and Improvement Methods. Acs Omega. 20441-20456.

Santos-Silva, A., Reis, F. and Belo, L. (2019) Chapter Twelve - Hepcidin in chronic kidney disease anemia. Vitamins and Hormones. 110:243-264.

Dasa, F. and Abera, T.(2018). Factors Affecting Iron Absorption and Mitigation Mechanisms: Areview.I nternational Journal of Agricultural Science and Food Technology. 4(1): 24 - 30.

South, p, K. and Miller, D, D. (1998) Iron binding by tannic acid: selected ligands. Food Chemisrry. 63(2): 167-172.

Shi, X, F., Ding, F., Zhu, Q, Y., Xue, J., Lu, F, M., Gu, Y. and Lin, ST. (2005). Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients. Ren Fail. 27(2):213-9.

Kontoghiorghes, G, J., Kolnagou, A., Kontoghiorghe, C, N., Mourouzidis, L., Timoshnikov, V, A. and Polyakov, N, E. (2020). Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications. Medicines. 7(8): 45.

Andrews, M., Briones, L., Jaramillo, A., Pizarro, F. and Arredondo, M. (2014). Effect of Calcium, Tannic Acid, Phytic Acid and Pectin over Iron Uptake in an In Vitro Caco-2 Cell Model. Biological Trace Element Research. 158(1): 122-127.

Srivastava, V., Sarkar, S., PattanayaK, C., Mishra, M. and Jena, J. (2020). Comparative Analysis of Haematinic Effect of Dhatryarista With Standard Ferrous Sulbhate in Tannic Acid Induced Iron Deficiency Anaemia in Albino Wistar Rats. World Gournal of Pharma Ceutical Research. 9(1): 1146-1155.

مصطفى، نشأت غالب؛ توفيق، فدوي خالد وعبد، مطاع عبد المطلب. (2005). تأثير التانين وفقر الدم على امتصاص الحديد الغذائي وبعض المظاهر الفسلجية في ذكور الجرذان. مجلة علوم الرافدين. 16(6): 236-248.

King, D., Fian, M, Z., Ejeta, G., Asem, E, K. and Adeola, O. (2000). The effects of tannins on nutrient utilisation in the white pek duke. Br Poult Sci. 41(5): 630.

Xiao, C., Lei, X., Wang, Q., Zhongyao, Du., Jiang, Lu., Chen, S., Zhang, M., Zhang, H. and Ren, F. (2016). Effects of a Tripeptide Iron on Iron-Deficiency Anemia in Rats. Biological Trace Element Research.169 (2): 211-217.

Vitale, S. G., Fiore, M., La Rosa, V, L., Rapisarda, A, M., Mazza, G., Paratore, M., Commodari, E. and Caruso, S. (2022). Liposomal ferric pyrophosphate and ascorbic acid supplementation in pregnant women with iron deficiency anaemia: haematochemical, obstetric, neonatal and psychological outcomes in a0 prospective observational study. International Journal of Food Sciences and Nutrition. 73(2): 221-229.

Malhotra, N., Kriplani, A., Pal, B., Bhat, V. and Swami, O. (2021). Ferrous Ascorbate: Current Clinical Place of Therapy in the Management of Iron Deficiency Anemia. Journal of South Asian Federation of Obstetrics and Gynaecology. 13(3).

Urso, K., Martinez-Bujanda, J, L. and Prado, J, D. (2021). Iron Protein Succinylate in the Management of Iron Deficiency Anemia: A Comparative Study with Ferrous Sulphate at Low and High Therapeutic Doses. Nutrients. 13(968).

Siegenberg, D., Baynes, R, D., Bothwell, T, H., Macfarlane, B, J., Lamparelli, R, D., Car, N, G., MacPhail, P., Schmidt, U., Tal, A. and Mayet, F. (1991). Ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on nonheme-iron absorption. The American Journal of Clinical Nutrition. 53(2): 537-551.

Lwanga, G, B. (2017). Efficacy of the aqueous root extract of Phyllanthus muellerianus in alleviating anemia in rats. Adissertation submitted to the university of Zambia in partial fulfilment for the award of master of science in biochemistry. The university of Zambia,Lusaka.

Barakat, H., Qureshi, k, A., Alsohim, A, S. and Rehan, M. (2022). The purified siderophore from streptomyces tricolor HM10 accelerates recovery from iron-deficiency-induced anemia. Molecules. 27(13): 4010.

Noor, U., Afsheen, A., Arshad, H. and Qamar, K. (2019). Effects of daily oral iron supplementation on histomorphology of rat placenta. Pakistan armed forces medical journal. 69(1): 15-20.

Uwaifo, F. and John-Ohimai, F. (2020). Body weight, organ weight, and appetite evaluation of adult albino Wistar rats treated with berberine. International Journal of Health & Allied Sciences. 9(4): 329-331.

Sharaf, Kh, H. and Thannoun, A, M. (1999). Iron Bioavailability of green leafy vegetables for anemic and healthy rats. Mesopotamia j .agric 31(4), 29-40.

الرفاعي، أمل إبراهيم ومحمود نبيلة يحي (2011). دراسات بيو كيميائية ونسيجية عند الدور المحسن لمنتجات الحلبة لأنيميا فقر الحديد المحدث بواسطة حمض التانيك في الجرذان البيضاء. الجمعية المصرية لعلم الأحياء التجريبي. 7(2): 185- 196.

Delimont, M, N., Haub, M, D. and Lindshield, B, L. (2017). 1(2): 1-12. The Impact of Tannin Consumption on Iron Bioavailability and Status: A Narrative Review. National Library of Medicinr National Center for Biotechnology Information. 1(2): 1-12.

Berber, I., Diri, H., Erkurt, M, A., Aydogdu, I., Kaya, E. and Kuku, I. (2014). Evaluation of ferric and ferrous iron therapies in women with iron deficiency anaemia. Adv Hematol.

Esposito, B, P., Breuer, W., Sirankapracha, P., Pootrakul, P., Hershko, C. and Cabantchik, Z, I. (2003). Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood. 102(7): 2670-2677.

Attallah, N., Osman-Malik, Y., Frinak, S. and Besarab, A. (2006). Effect of Intravenous Ascorbic Acid in Hemodialysis Patients With EPO-Hyporesponsive Anemia and Hyperferritinemia. American Journal of Kidney Diseases. 47(4): 644-654.

Deicher, R., Ziai, F., Habicht, A., Bieglmayer, C., Schillinger, M. and Horl, W, H. (2004). Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. Nephrol Dial Transplant. 19(9): 2319-2324.

Agarwal, M, B. (2007). Ferrous ascorbate: the novel, highly bioavailable iron. BMJ South Asia. 23(1):17–19.